Related Experiment Video
Updated: Dec 25, 2025
06:15
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
1.3K
Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation
Christine M Lin1, Martin R Zamora2
11University of Colorado, Denver - Anschutz Medical Campus, 12700 East 19th Avenue, Room 9470E, Aurora, CO 80045 USA.
Current Transplantation Reports
|April 1, 2020
Summary
Lung transplantation is vital for end-stage lung disease, but chronic allograft dysfunction, specifically bronchiolitis obliterans syndrome (BOS), limits long-term success. Understanding BOS pathogenesis is crucial for improving patient outcomes after lung transplants.
Area of Science:
- Pulmonology
- Transplantation Immunology
- Surgical Sciences
Background:
- Lung transplantation offers a critical treatment for end-stage lung disease.
- Chronic allograft dysfunction, particularly bronchiolitis obliterans syndrome (BOS), significantly limits long-term transplant success.
- BOS is histologically defined by airway fibrosis and clinically by a decline in forced expiratory volume (FEV1).
Purpose of the Study:
- To review the known risk factors associated with the development of BOS.
- To highlight the poorly understood pathogenesis of BOS.
- To underscore the limited treatment options for progressive lung function decline in BOS.
Main Methods:
- Literature review of risk factors for BOS.
- Analysis of histological and clinical definitions of BOS.
- Examination of current understanding of BOS pathogenesis.
Main Results:
- Several risk factors for BOS have been identified, including acute rejection, infection, and donor-specific antibodies.
- Despite identified risk factors, the underlying mechanisms driving BOS remain largely unknown.
- Few effective treatments exist to reverse or halt the progression of lung function loss in BOS.
Conclusions:
- Chronic allograft dysfunction, specifically BOS, remains a major challenge in lung transplantation.
- Further research into the pathogenesis of BOS is essential for developing effective therapeutic strategies.
- Improving long-term lung transplant outcomes requires a deeper understanding and better management of BOS.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.4K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.4K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
01:21Acute Respiratory Failure-II
923
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
923
01:22Chronic Obstructive Pulmonary Disease
2.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K